Precision Fluidics Market Size, Share & Trends Analysis Report By Component (Pumps, Valves, Probes, Degassers, Fluidic Systems, Manifolds, Pressure Sensors, Flow Sensors, Fluid Level Sensors, Inline Filters, Subsystem Level-Fluidics Systems or Integration), By Application, By Region, And By Segment Forecasts, 2024-2031
The Precision Fluidics Market Size is valued at USD 6.79 Billion in 2023 and is predicted to reach USD 12.63 Billion by the year 2031 at an 8.20 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The expanding use of microfluidics in point-of-care diagnostics and the miniaturization of devices for improved efficiency are further propelling market growth. The lack of awareness and ...
Report ID: 1405 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 175
Novel Drug Delivery Systems In Cancer Therapy Market Size, Share & Trends Analysis Report By Product (Nanoparticles, Embolization Particles), By Region, And by Segment Forecasts, 2024-2031
The Novel Drug Delivery Systems In Cancer Therapy Market Size is valued at USD 12.71 Billion in 2023 and is predicted to reach USD 63.25 Billion by the year 2031 at a 22.41 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The ability of novel drug delivery systems to deliver targeted therapies provides opportunities for personalized medicine. Advances in targeted therapies, including...
Report ID: 1440 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 175
Cervical Spondylosis Diagnosis & Treatment Market Size, Share & Trends Analysis Report By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, Nerve Conduction Study), By Product Type (Medications, Medical Devices, Surgical Instruments), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031.
Cervical Spondylosis Diagnosis & Treatment Market Size is valued at USD 6.19 Bn in 2023 and is predicted to reach USD 10.14 Bn by the year 2031 at a 6.3% CAGR during the forecast period for 2024-2031. Cervical spondylosis is a degenerative disorder that affects the neck region and is treated with therapy. These therapies reduce discomfort, boost mobility, and forestall nerve and spinal cord degeneration. Pain and stiffness can be experienc...
Report ID: 2430 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Pitavastatin Market Size, Share & Trends Analysis Report, By Type (1 mg, 2 mg and 5 mg), By Product Type (Tablets, Capsules and Oral Solution), By Application (Hyperlipidemia and Cardiovascular Disease Prevention), By End-user (Hospitals, Clinics, Retail Pharmacies, And Online Pharmacies), By Region, Forecasts, 2024-2031
Pitavastatin Market Size was valued at USD 537.1 Mn in 2023 and is predicted to reach USD 890.2 Mn by 2031 at a 6.7% CAGR during the forecast period for 2024-2031. The increasing awareness of preventive healthcare measures and the significance of managing cardiovascular risk factors are driving the demand for pitavastatin as a preventive medication. Opportunities exist to expand the global reach of the pitavastatin market, tap into emerging ma...
Report ID: 2421 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
DTC Wellness Testing Market Size, Share & Trends Analysis Report By Type (Genetic Testing, Metabolic Testing, Nutritional Testing, Hormone Testing, Others), By Application (Disease Risk Assessment, Ancestry Testing, Fitness and Nutrition, Personalized Medicine, Others), By Product, By Technology, Region And Segment Forecasts, 2024-2031
Global DTC Wellness Testing Market Size is valued at USD 973.30 Mn in 2023 and is predicted to reach USD 3,518.77 Mn by the year 2031 at a 17.79% CAGR during the forecast period for 2024-2031. The global market for (DTC) genetic testing encompasses regions where genetic testing services and products are directly marketed and sold to consumers, bypassing medical professionals or intermediaries. DTC genetic testing enables individuals to obtain ...
Report ID: 2317 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Genome Editing/Genome Engineering Market Size, Share & Trends Analysis Report By Technology (CRISPR, TALEN, ZFN, Antisense, and Other Technologies), By Products, By Application, By End Users, Region And Segment Forecasts, 2023-2031.
The Genome Editing/Genome Engineering Market Size is valued at 5900.0 Million in 2022 and is predicted to reach 28469.3 Million by the year 2031 at a 19.20 % CAGR during the forecast period for 2023-2031. Genome engineering is the technique that involves gene modification by certain process include DNA is insertion, cutting, modification or replacement of genome of a living organism. Due to increasing the research and development spend by comp...
Report ID: 1174 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Alpha 1 Lung Disease Market Size, Share & Trends Analysis Report By Disease Type (Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Fibrosis, Bronchiectasis, Others), By Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, Lung Transplantation, Others), By Route of Administration, By Distribution Channel, By End User, By Region, And By Segment Forecasts, 2023-2031.
Alpha 1 Lung Disease Market Size is valued at USD 4.13 Billion in 2022 and is predicted to reach USD 19.93 Billion by the year 2031 at a 19.33% CAGR during the forecast period for 2023-2031. Alpha-1 Antitrypsin Deficiency is a genetic disorder in which the body does not make enough of a protein known as alpha-1 antitrypsin. This protein is very important for keeping the lungs safe from damage caused by inflammation. People who don't get enough...
Report ID: 2274 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Nucleic Acid Sample Preparation Market Size, Share & Trends Analysis Report By Product (Consumables (Kits (DNA/RNA Sample Isolation/Extraction/Purification, DNA/RNA Clean-Up and Concentration, DNA and RNA Quantification), Reagents), Instruments), By Technology (Silica-Based, Magnetic Particle Technology), By Source Type, By Application, By End-user, By Region, And By Segment Forecasts, 2024-2031
Nucleic Acid Sample Preparation Market Size is valued at USD 2.89 Billion in 2023 and is predicted to reach USD 4.57 Billion by the year 2031 at a 6.10% CAGR during the forecast period for 2024-2031. Molecular biology relies on nucleic acid sample preparation to extract, purify, and concentrate DNA or RNA from blood, tissue, cell, and environmental samples. High-quality nucleic acids are essential for genetic and molecular analysis like PCR, N...
Report ID: 2386 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 179
Swab And Viral Transport Medium Market Size, Share & Trends Analysis Report By Product (Swab Type (Nasal Swabs, Nasopharyngeal Swabs and Throat Swabs), Transport Medium), By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031
The Swab And Viral Transport Medium Market Size is valued at 8.09 Billion in 2023 and is predicted to reach 13.16 Billion by the year 2031 at a 6.47 % CAGR during the forecast period for 2024-2031. Viral transport medium is used to collect, transport, maintain and store the clinical specimens containing viruses, chlamydia, mycoplasma or ureaplasma organisms. A viral skin swab is lightly rubbed against a visible skin lesion or vesicle and ...
Report ID: 1125 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Combo IVD Market Size, Share & Trends Analysis Report By Test Type (SARS-CoV-2 Flu A/B Combo Test, COVID-19, Influenza A/B, RSV Combo test, COVID-19 IgM/IgG Combo Test, HIV-1/2 Ag/Ab Combo Test, HIV/Syphilis Ab Combo Test, HIV, HBsAg, HCV & Syphilis Combo, hCG Combo Test, Thrombophilia Detection Combo Test, Other Test Types), By Testing, By End-User, By Channel, By Sample Type, By Region, And By Segment Forecasts, 2024-2031
Combo IVD Market Size is valued at USD 550.12 Mn in 2023 and is predicted to reach USD 920.86 Mn by the year 2031 at a 6.84% CAGR during the forecast period for 2024-2031. Combo in vitro diagnostics (IVDs) refers to medical tools that measure and analyze biological samples in a controlled environment. These tests are useful for detecting and monitoring a wide range of medical illnesses, including infectious disorders and autoimmune diseases. T...
Report ID: 2376 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Pharmaceuticals